Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan
Open Access
- 19 March 2022
- journal article
- research article
- Published by Wiley in International Journal of Hypertension
- Vol. 2022, 1-7
Abstract
Background. The differences in the antihypertensive treatment with angiotensin type II receptor blockers (ARBs) may be attributed to polymorphisms in genes involving drug-targeted receptor and drug metabolism. The present study aimed to investigate whether the antihypertensive effect of the ARB drug valsartan was associated with angiotensin II type 1 receptor (AGTR1) gene polymorphism (A1166 C) and cytochrome P450 enzyme 2C9 (CYP2C9) gene polymorphism (CYP2C9∗3). Methods. 281 patients with hypertension who received valsartan monotherapy in the past month were included in this retrospective study. Polymerase chain reaction-melting curve analysis was performed to genotype the AGTR1 and CYP2C9 gene polymorphisms. Based on the systolic blood pressure (SBP) and diastolic blood pressure (DBP) at the time of visit, the patients were divided into well-controlled group (n = 144, SBP/DBP n = 137, SBP/DBP ≥140/90 mmHg). Results. Older age, decreased history of drinking, a higher proportion of mild-to-moderate hypertension, lower alanine aminotransferase levels, and higher high-density lipoprotein cholesterol levels were observed in the well-controlled group than the poorly controlled group. Higher frequencies of the C allele and AC + CC genotype of AGTR1 A1166C were detected in the well-controlled than the poorly controlled patients ( = 0.005 and = 0.006). After adjustment for demographic and environmental factors, the CC + AC genotype of AGTR1 A1166C was markedly linked to better hypertension control with valsartan treatment compared to the AA genotype (odds ratio: 2.836, 95% confidence interval: 1.199–6.705, = 0.018). No significant difference was observed in the allele or genotype distribution of CYP2C9∗3 polymorphism between well-controlled and poorly controlled patients. Conclusions. The current data suggested that the AGTR1 A1166 C polymorphism may be associated with the antihypertensive effect of valsartan, and carriers with AC and CC genotypes may have a better antihypertensive efficacy response to valsartan treatment.Keywords
Funding Information
- Horizontal Scientific Research Project (2019-HX-28, 2020, 82074221, ZRJY2021-GG03)
- key clinical specialty project of Beijing (2019-HX-28, 2020, 82074221, ZRJY2021-GG03)
- National Natural Science Foundation of China (2019-HX-28, 2020, 82074221, ZRJY2021-GG03)
- China-Japan Friendship Hospital (2019-HX-28, 2020, 82074221, ZRJY2021-GG03)
This publication has 36 references indexed in Scilit:
- Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 IndividualsHypertension, 2011
- Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartanJournal Of Hypertension, 2011
- Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysisJournal of the Renin-Angiotensin-Aldosterone System, 2010
- Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor BlockersDiabetes Care, 2009
- CYP2C9 lle359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensivesMethods and Findings in Experimental and Clinical Pharmacology, 2006
- CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese populationEuropean Journal of Clinical Pharmacology, 2005
- CYP2C9 allele variants in Chinese hypertension patients and healthy controlsClinica Chimica Acta, 2004
- CYP2C9 genetic variants and losartan oxidation in a Turkish populationEuropean Journal of Clinical Pharmacology, 2004
- A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen geneJournal of Human Genetics, 2004
- Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-proteinBiochemical Journal, 2003